Fulcrum Asset Management LLP boosted its position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 4,634.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,030 shares of the company’s stock after acquiring an additional 2,966 shares during the period. Fulcrum Asset Management LLP’s holdings in Molina Healthcare were worth $574,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of MOH. BlackRock Inc. purchased a new stake in shares of Molina Healthcare during the second quarter worth about $1,503,052,000. Dimensional Fund Advisors LP increased its holdings in shares of Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock valued at $185,929,000 after acquiring an additional 267,121 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Molina Healthcare by 11.9% in the 2nd quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company’s stock valued at $289,810,000 after purchasing an additional 135,247 shares during the last quarter. Manning & Napier Advisors LLC purchased a new position in shares of Molina Healthcare in the 2nd quarter valued at approximately $152,339,000. Finally, Maverick Capital Ltd. acquired a new stake in Molina Healthcare in the 1st quarter worth approximately $86,081,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Trending Headlines about Molina Healthcare
Here are a few of the latest headlines about MOH:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $9.55 from $9.24 and FY2028 estimate to $12.44 from $12.19, alongside increases to several quarterly forecasts. These upgrades point to improved longer-term earnings expectations, although Zacks kept its rating at Hold. Molina Healthcare analyst estimates
- Negative Sentiment: Zacks cut its Q4 2026 EPS forecast to $0.52 from $0.69, a sizable reduction that offsets some of the longer-term upgrades. Zacks Research earnings estimates
- Negative Sentiment: Insiders reported stock sales, including Director Richard Schapiro’s sale of 782 shares for about $159,000 and a separate report that the company’s legal chief sold about $1.62 million of stock. Insider sales can concern investors, though they do not by themselves indicate deteriorating business fundamentals. Richard Schapiro stock sale Molina legal chief stock sale
Molina Healthcare Stock Performance
NYSE MOH opened at $209.37 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.69. The stock’s 50 day simple moving average is $202.56 and its 200-day simple moving average is $185.69. The company has a market cap of $10.93 billion, a PE ratio of -218.09, a price-to-earnings-growth ratio of 12.35 and a beta of 0.74. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89.
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.10. The firm had revenue of $11.08 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period last year, the firm posted $1.84 earnings per share. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 5.30 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on MOH. Mizuho set a $255.00 target price on shares of Molina Healthcare in a research report on Friday, October 23rd. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Molina Healthcare in a report on Friday, October 9th. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, October 24th. UBS Group upped their target price on Molina Healthcare from $202.00 to $225.00 and gave the company a “neutral” rating in a research report on Friday, October 23rd. Finally, Morgan Stanley upped their target price on Molina Healthcare from $167.00 to $192.00 and gave the company an “equal weight” rating in a research report on Friday, October 23rd. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $213.88.
Check Out Our Latest Research Report on MOH
Insider Buying and Selling
In other Molina Healthcare news, Director Richard M. Schapiro sold 782 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $203.94, for a total value of $159,481.08. Following the completion of the transaction, the director owned 11,833 shares of the company’s stock, valued at $2,413,222.02. This trade represents a 6.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Dale B. Wolf sold 1,600 shares of the company’s stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $206.12, for a total value of $329,792.00. Following the sale, the director owned 14,337 shares in the company, valued at approximately $2,955,142.44. This trade represents a 10.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 10,382 shares of company stock valued at $2,113,833. Company insiders own 1.44% of the company’s stock.
Molina Healthcare Profile
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Featured Stories
- Five stocks we like better than Molina Healthcare
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
